MLTXMoonLake Immunotherapeutics

$15.61

Who owns MLTX

144 institutions reported holding MLTX for 2026Q1, together 88% of the company, more than the 127 a quarter earlier.

144

Institutions reporting a position · as of 2026Q1 · up from 127 the quarter before

Shares held by institutions
63.0M

Shares held by institutions · 88% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.17B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
46%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
17
New positions
36
Positions exited
20
Added to
48
Reduced
41
Top 10 holdersof the company
57%
Institutional ownership by quarter, 2022Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q114463.0M$1.17B
2025Q412756.3M$743M
2025Q313337.5M$268M
2025Q212858.6M$2.76B
2025Q113359.7M$2.33B
2024Q411363.2M$3.42B
2024Q310762.1M$3.13B
2024Q210960.6M$2.67B
2024Q111259.3M$2.98B
2023Q412459.3M$3.53B
2023Q311756.3M$3.21B
2023Q28256.1M$2.86B
2023Q14339.4M$843M
2022Q43337.7M$396M
2022Q32436.9M$291M
2022Q22336.5M$190M
Largest reported holders, 2026Q1
HolderShares% of companyValue
BVF INC/IL16.0M22%$298M
Deep Track Capital, LP6.4M9.0%$119M
Cormorant Asset Management, LP4.5M6.3%$84M
HENDERSON GROUP PLC3.5M4.8%$64M
D. E. Shaw & Co., INC.2.4M3.4%$45M
MPM BIOIMPACT LLC1.8M2.5%$34M
Weiss Asset Management LP1.7M2.4%$32M
Logos Global Management LP1.5M2.1%$28M
Point72 Asset Management, L.P.1.4M1.9%$26M
CITADEL ADVISORS LLC1.3M1.9%$25M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…